RFK Jr. praises cane sugar
Kennedy has repeatedly blasted high-fructose corn syrup — a staple of sugary snacks and drinks including Coke — as a driver of obesity and diabetes. And research has established that added sugar in food does fuel those chronic diseases.
Get Love Letters: The Newsletter
A weekly dispatch with all the best relationship content and commentary – plus exclusive content for fans of Love Letters, Dinner With Cupid, weddings, therapy talk, and more.
Enter Email
Sign Up
Cane sugar is also an unhealthy addition to drinks, the experts said.
Advertisement
'Replacing one sugar with another isn't going to have much of an effect on health,' said Dariush Mozaffarian, director of the Food Is Medicine Institute at Tufts University, who praised other Kennedy food priorities, such as reducing consumption of ultra-processed foods.
The Department of Health and Human Services declined to comment. Some Kennedy allies defended his comments, saying they were not contradictory and instead highlighted concerns over a pesticide commonly sprayed on corn.
'Of course, Coca-Cola is not a healthy drink. Of course, it still has a ton of sugar and is nutritionally void,' said Vani Hari, an author and activist known as the Food Babe.
Advertisement
But Kennedy is 'looking at the bigger picture,' Hari added. 'He understands how food is produced in this country. He understands the downstream impacts on human health.'
Many US customers are already familiar with the Mexican version of Coke made with cane sugar because it is widely imported. President Donald Trump, known for his love of Diet Coke, said last week that he had spoken to Coca-Cola about making its product in the US with cane sugar and that the company agreed. At the time, Coca-Cola did not confirm the move, but the company said in a statement that it appreciated Trump's 'enthusiasm' for its brand.
The company said the addition of a soda with cane sugar in the US 'is designed to complement the company's strong core portfolio and offer more choices across occasions and preferences.' James Quincey, Coca-Cola's chief executive, said some of its other drinks sold in the US already use cane sugar, such as teas and lemonades.
'We are definitely looking to use the whole toolbox, the whole tool kit of available sweetening options to some extent where there are consumer preferences,' Quincey said on a Tuesday earnings call.
Trump's preview of the decision revived a long-running debate over whether 'Mexican Coke' made with cane sugar tastes better. Nutrition experts bristled at the focus on the type of sugar in the drink instead of whether people should be drinking it at all.
'To actually improve health, the administration should focus on less sugar, not different sugar,' said Aviva Musicus, science director of the nonprofit Center for Science in the Public Interest, which advocates a healthy and safe food supply.
Advertisement
Cane sugar, derived from a sucrose-rich plant, and high-fructose corn syrup, made by breaking down corn starch and processing it, share similar compositions with slight differences in their makeup. The Food and Drug Administration says it is not aware of evidence showing a difference in the safety of foods containing the syrup versus other sweeteners such as sucrose, also known as table sugar, and honey.
Several nutritionists said they have not seen scientific evidence showing sucrose is healthier than high-fructose corn syrup in food. They pointed to a 2022 study indicating that both have similar effects on weight, blood pressure, and body mass index.
'Biochemically and physiologically, they're the same,' said Marion Nestle, a retired professor of nutrition, food studies, and public health at New York University. 'They're sugars. Everybody should be eating less of them.'
More than three-quarters of children five years and older and more than half of adults consume more than the recommended limit of added sugars, according to US data from the National Health and Nutrition Examination Survey.
Kennedy has long targeted high-fructose corn syrup and touted 'Mexican Coke' over the version manufactured in the U.S.
'High-fructose corn syrup. That is poison. … Clearly it is linked to the obesity epidemic. It's linked to the diabetes epidemic,' Kennedy said on a 2023 episode of 'The Breakfast Club,' a radio show.
He added, 'If you're going to drink Coca-Cola, drink a Mexican Coke because they don't have it in it.'
But public health experts have long raised alarms about soda consumption in Mexico. According to one 2019 study, nearly a fifth of all deaths of Mexican adults due to diabetes, cardiovascular disease, or obesity-related cancer were attributable to sugar-sweetened beverages. At one point, the drinks contributed to more than 40,000 excess deaths per year in Mexico.
Advertisement
A May report from the Trump administration's MAHA commission - which Kennedy chairs - said high-fructose corn syrup and other added sugars 'may play a significant role in childhood obesity, Type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD).'
Embed code:
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
2 hours ago
- Miami Herald
Covid-19 drug company liquidates assets in Chapter 11 bankruptcy
When the Covid-19 public health crisis began in the U.S. with the first confirmed case of the 2019 Novel Coronavirus in Washington state on Jan. 20, 2020, the terrifying pandemic was underway, and the Centers for Disease Control and Prevention would report its first confirmed death from the virus on Feb. 29. By March 3, 2020, CDC reported 60 confirmed cases in 12 states. On March 13, the first Trump administration declared a national emergency, and states started implementing shutdowns on March 15, according to the CDC's timeline of Covid-19 events. Don't miss the move: Subscribe to TheStreet's free daily newsletter Biotechnology firms Pfizer-BioTech and Moderna Therapeutics began developing Covid-19 vaccines in March 2020, and by November 2020, each company's Covid-19 vaccine would be found 95% effective in clinical trials. Related: CVS rival pharmacy chain files for Chapter 11 bankruptcy Another biotech firm, Regeneron, in November received approval of an antibody treatment to significantly reduce virus levels within days. In December 2020, Covid-19 vaccinations began, and by Dec. 24, 1 million people had been vaccinated in the U.S. CDC said that by June 1, 2022, the U.S. reported over 84 million Covid-19 infections and over 1 million deaths. About a year later, Pfizer reported on its website that on May 5, 2023, the World Health Organization declared an end to the Covid-19 public health emergency, while the U.S. Department of Health & Human Services did the same on May 11, 2023. The healthcare industry's response to the Covid-19 pandemic was so effective that beginning on May 1, 2024, hospitals were no longer required to report Covid-19 hospital admissions, hospital capacity, or hospital occupancy data to the U.S. Department of Health & Human Services through the Centers for Disease Control and Prevention's National Healthcare Safety Network, according to the CDC website. The end of the crisis also ended the need for massive amounts of Covid-19 drugs. With the Covid-19 pandemic subsiding, companies that stepped forward to develop vaccines, drugs, and treatments during the crisis are now facing declining demand for their services to develop Covid-19 products. With no dire need for Covid-19 products, some drug companies have been forced to downsize or even shut down operations because of a lack of business opportunities. Essential drug manufacturer Aluchua Government Services Inc., which developed Covid-19 therapy drugs under U.S. government contracts, has filed for Chapter 11 bankruptcy with plans to wind down operations and sell its assets. Related: Giant healthcare company files Chapter 11 bankruptcy seeking sale The Aluchua, Fla.-based pharmaceutical company filed its petition in the U.S Bankruptcy Court for the District of Delaware, listing $50 million in assets and $100 million to $500 million in liabilities. The debtor's largest creditors include United States International Development Finance Corp., owed $246 million; Defense Contract Management Agency, owed $11.95 million; and Sigma-Aldrich Inc. $1.33 million. Aluchua was founded in 1999 to develop new drugs and to increase efficacy of existing ones. In 2013, it was awarded a greenfield contract with the U.S. Department of Defense, and in February 2020, it was awarded a contract to develop an advanced monoclonal antibody therapy against Covid-19 infection. The Covid-19 drug was one of several that the debtor partnered with the U.S. government to develop and produce drugs, vaccines, and treatments. The debtor needed to file for Chapter 11 protection after demand for its services began to decline in late 2023 and certain government contracts were wound down or scaled back, according to Aluchua's Chief Restructuring Officer Janet R. Naifeh of FTI Consulting Inc. Aluchua's efforts to replace its government business with commercial contracts failed, which forced it to scale down production and lay off 125 employees from January through April 2025. It reduced its staff by another 67 employees on June 20 and July 1, which, combined with the earlier layoffs, amounted to termination of 80% of its workforce. The company employed 13 full-time and three temporary workers as of the petition date. The company marketed itself for sale beginning in February 2025, but was unable to complete a transaction and decided its only viable option was to file for Chapter 11 bankruptcy, wind down its business, and sell its assets. Related: Iconic retail chain closing its remaining stores in bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Axios
2 hours ago
- Axios
RFK Jr. greenlights removing preservative from flu shots
The Health and Human Services Department on Wednesday said it adopted a recommendation from Secretary Robert F. Kennedy Jr.'s vaccine advisers to remove from all influenza shots a preservative that anti-vaccine activists have suggested is linked to autism. Why it matters: The move hinged on the widely discredited belief that the mercury-containing compound, thimerosal, is harmful at the level at which it's included in vaccines. Despite the lack of evidence of harm, most Americans who get flu vaccines already receive products without thimerosal. The latest: Kennedy, in a statement, said the action fulfilled a promise to protect vulnerable populations from unnecessary mercury exposure. "Injecting any amount of mercury into children when safe, mercury-free alternatives exist defies common sense and public health responsibility," Kennedy said. "Today, we put safety first." The Centers for Disease Control customarily acts on such recommendations. But because the CDC lacks a full-time political leader, Kennedy signed the recommendation. HHS said that vaccine manufacturers confirmed that they have the capacity to replace multi-dose vials containing the preservative so that the federal Vaccines for Children program and adult vaccine supplies won't be interrupted. Kennedy's handpicked vaccine advisors voted 5-1 last month to no longer recommend that that Americans get flu shots containing thimerosal, following a presentation from a retired nurse and former president of Children's Health Defense, the anti-vaccine group with close ties to Kennedy.
Miami Herald
4 hours ago
- Miami Herald
Popular soda brand unveils surprising collaboration to rival Pepsi
Just a few years ago, drinking full-sugar soda was a daily habit for consumers. Traditional soft drinks dominated grocery store shelves and comprised a significant portion of most people's daily intake. But with the growing awareness around health and wellness and a bit of social media brainwashing, consumer preferences have shifted dramatically. This has increased demand for healthier alternatives and nonalcoholic beverages, especially those offering health benefits. Don't miss the move: Subscribe to TheStreet's free daily newsletter Prebiotic soda has become one of the fastest-growing segments in the beverage industry, so much so that even giants like PepsiCo have reported revenue declines in the U.S. market, once its most profitable client. Related: Coca-Cola brings back controversial Coke flavor As traditional soda brands struggle, startups like Olipop, Poppi, and Culture Pop thrive. These brands have experienced astronomical growth in just a few years, outdoing what even the most veteran companies achieved in decades by listening to consumers' demands. Image source: TheDriven by skyrocketing demand for healthier soda alternatives and gut-friendly drinks, PepsiCo (PEP) acquired Poppi for $1.95 billion in May. Despite being officially founded four years ago, Poppi achieved over $100 million in revenue in 2024, with a gross margin of 65%. This market a significant leap from its initial $30 million in sales back in 2020, placing it among the fastest-growing soda brands in the U.S. PepsiCo stated that this acquisition aligns with the company's short- and long-term strategy to meet changing consumer preferences and capture market share in the beverage space. Related: Pepsi to buy popular alternative brand to destroy rival This move comes at a critical time for PepsiCo, which has faced troublesome declines over the past few months. The company reported a 2% drop in its North American beverages division during the second quarter of 2025, highlighting a shift in consumer behavior. PepsiCo didn't take long to enter the soda market with its own innovation. On July 21, the company announced the launch of its first-ever prebiotic cola, available in Original and Cherry Vanilla flavors. This marks PepsiCo's first major innovation in the category in 20 years. Since its launch in 2018 with an initial investment of $100K, Olipop has become a force to be reckoned with. In only seven years, the prebiotic soda brand has reached a $1.85 billion valuation with profits of approximately $50 million, another testament to the growing consumer demand for functional health beverages. However, the competition is getting more challenging, which prompted Olipop to reveal a new partnership only a day after PepsiCo's prebiotic soda was launched. More Retail News: Taco Bell reveals new menu item with dream partnerPapa Johns announces wild new menu deal to win back customersTarget is ending price matching - Here's where you can still save Olipop has partnered with the Nickelodeon character SpongeBob SquarePants to release the new "Olipop X The SpongeBob Movie Pineapple Paradise" flavor for the upcoming "The SpongeBob Movie: Search for SquarePants." The collaboration features five different SpongeBob can designs, each containing prebiotics, plant fiber, botanicals, pineapple, and a splash of mandarin. Paramount Global is the parent company to Nickelodeon, where the "SpongeBob SquarePants" show airs. The limited-time flavor has been listed at Walmart and HEB. Although no specific stores have been announced, Olipop is sold at nearly all major retailers, including Target, Whole Foods, and Kroger. Related: Veteran fund manager unveils eye-popping S&P 500 forecast The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
